on 29 Nov 2024
Last Applicant/ Owned by
Applied Therapeutics, Inc.
545 Fifth AvenueSuite 1400New York, NY 10017
US
Serial Number
2140735 filed on 18th Oct 2021
Correspondent Address
SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO
ONTARIO
CA
M5H3Y2
NUGALVIQ & Design
Vienna Information
26 . 1 . 1
CirclesCercles
26 . 1 . 6
Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant
26 . 1 . 24
Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée
26 . 11 . 3
More than two lines or two bandsPlus de deux lignes ou de deux bandes
26 . 11 . 12
Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)
26 . 11 . 14
Dotted lines or bandsLignes ou bandes pointillées
Trademark usage description
pharmaceutical preparations for treatment of rare orphan diseases; pharmaceutical preparations for treatment of diseases that impact sugar and glucose Read MoreClassification Information
Class [005]
Pharmaceutical preparations for treatment of rare orphan diseases; pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; pharmaceutical preparations for inhibiting aldose reductase; pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)
Classification kind code
11
Mark Details
Serial Number
2140735
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 22 on 29th Nov 2024 | Search Recorded |
| Submitted for opposition 20 on 29th Nov 2024 | Examiner's First Report |
| Submitted for opposition 67 on 27th Sep 2024 | Agent Name Changed |
| Submitted for opposition 287 on 11th Jul 2022 | Pre-Assessment Letter Sent |
| Submitted for opposition 30 on 18th Oct 2021 | Filed |
| Submitted for opposition 1 on 18th Oct 2021 | Created |
| Submitted for opposition 31 on 18th Oct 2021 | Formalized |